Clinical Trials Logo

Filter by:
  • No longer available  
  • Page [1]
NCT ID: NCT04360486 No longer available - Clinical trials for Severe Acute Respiratory Syndrome Coronavirus 2

Treatment Of CORONAVIRUS DISEASE 2019 (COVID-19) With Anti-Sars-CoV-2 Convalescent Plasma (ASCoV2CP)

Start date: n/a
Phase:
Study type: Expanded Access

This treatment protocol is designed to provide convalescent plasma as a therapeutic option for patients diagnosed with and hospitalized for COVID-19 with symptoms ranging from mild to life-threatening.

NCT ID: NCT04302766 No longer available - Clinical trials for Coronavirus Disease 2019

Expanded Access Remdesivir (RDV; GS-5734™)

Start date: n/a
Phase:
Study type: Expanded Access

Disease caused by 2019 Novel Coronavirus also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)